SB 203580, a pyridinyl imidazole, has been observed to suppress p38 mediated activation of MAPKAP kinase-2 (MAPKAPK-2 or MK2), yet does not disrupt JNK activity.Mitogen-activated protein kinases (MAPK) are a group of serine and threonine-specific kinases sensitive to cellular stress, heat shock, and proinflammatory cytokines. p38 (p38 MAPK) is crucial for normal inflammatory and immune responses as it regulates the expression of varying cell surface receptors, cytokines and transcription factors. SB 203580 inhibits heat shock protein 27 (HSP 27) phosphorylation and has been shown to induce the activation of Raf-1. SB 203580 has also been shown to inhibit phosphoinositide-dependent protein kinase 1 (PKB Kinase), consequently preventing the activation of PKB/Akt. SB 203580 is a useful tool to assess the physiological roles of p38, and for deriving and maintaining embryonic stem cells. SB 203580 is an inhibitor of p38 α, p38 β, Cox-1, Cox-2, GSK, TXA Synthase and RICK.
1. Cuenda, A., et al. 1995. FEBS Lett. 364: 229-233. PMID: 7750577
2. Saklatvala, J., et al. 1996. J. Biol. Chem. 271: 6586-6589. PMID: 8636072
3. Young, P.R., et al. 1997. J. Biol. Chem. 272: 12116-12121. PMID: 9115281
4. Clerk, A. and Sugden, P.H. 1998. FEBS Lett. 426: 93-96. PMID: 9598985
5. Hashimoto, S., et al. 1999. Biochem. Biophys. Res. Commun. 258: 443-447. PMID: 10329406
6. Kalmes, A., et al. 1999. FEBS Lett. 444: 71-74. PMID: 10037150
7. Hall-Jackson, C.A., et al. 1999. Oncogene. 18: 2047-2054. PMID: 10321729
8. Qi, X., et al. 2004. Proc. Natl. Acad. Sci. U.S.A. 101: 6027-6032. PMID: 15075392
9. Cao, W., et al. 2006. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G672-G680. PMID: 16645161
See how others have used SB 203580. Click on the entry to view the PubMed entry .
PMID: # 30484005 Shindo, S.|Hosokawa, Y.|Hosokawa, I.|Shiba, H.| et al. 2019. Inflammation. 42: 835-840.
PMID: # 30496826 Youssef, M.|Ibrahim, A.|Akashi, K.|Hossain, MS.| et al. 2019. Neuroscience. 397: 18-30.
PMID: # 30668359 Lin, FZ.|Wang, SC.|Hsi, YT.|Lo, YS.|Lin, CC.|Chuang, YC.|Lin, SH.|Hsieh, MJ.|Chen, MK.| et al. 2019. Phytomedicine. 54: 1-8.
PMID: # 31179339 Cui, FQ. et al. 2019. J Diabetes Res. 2019: 2981705.
PMID: # 31071576 Li, Y.|Zuo, H.|Wang, H.|Hu, A.| et al. 2019. Biomed. Pharmacother. 116: 108749.
PMID: # 30783129 Klarström Engström, K. et al. 2019. Sci Rep. 9: 2296.
PMID: # 30783082 2019. Int J Oral Sci. 11: 6.
PMID: # 9951446 2019. CMAJ. 160: 225-32.
PMID: # 30602116 Klug, YA. et al. 2019. Biochemistry. 58: 818-832.
PMID: # 31356638 Wang, C.|Puerta-Guardo, H.|Biering, SB.|Glasner, DR.|Tran, EB.|Patana, M.|Gomberg, TA.|Malvar, C.|Lo, NTN.|Espinosa, DA.|Harris, E.| et al. 2019. PLoS Pathog. 15: e1007938.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.
Email address is required. Please provide a valid email address.
{* #socialRegistrationForm *} {* emailAddress *} {* firstName *} {* lastName *}